Intellectual Property

We are pleased to present the first in a series of webinars relating to Goodwin’s Guide to Biosimilars Litigation and Regulation in the U.S. which provides expert guidance and practical know-how for lawyers working in this growing area of the law. The first webinar, So You Want To Make A Biosimilar? Top Considerations Before You Start, will take place tomorrow, Wednesday, April 8th. Big Molecule Watch editors Mike Cottler, Cindy Chang and Keith
Music copyright has proven to be a tricky topic in recent years, given how readily available music is at present paired with the ability to take on alleged infringement, both through YouTube and in the courts. (Not that any court case would ever be considered easy.) The exponential growth in copyright cases within music is a matter of some debate and contention; some believe in the absolute ability of creators to protect their work from…
There are currently two COVID-19 related acts:  The Families First Coronavirus Response Act (“FFCRA”) and the Coronavirus Aid, Relief, and Economic Security (CARES) Act. I know everyone wants to know about the Payroll Protection Program under the CARES Act. We’ve been looking at it and talking to banks, but let’s address the Families First Act first because if you haven’t done the following, you need to act on that promptly. The FFCRA requires companies under…

Intellectual Property Blogs